Structure

Physi-Chem Properties

Molecular Weight:  416.18
Volume:  429.691
LogP:  4.809
LogD:  2.073
LogS:  -3.553
# Rotatable Bonds:  7
TPSA:  128.2
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.398
Synthetic Accessibility Score:  3.271
Fsp3:  0.391
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.036
MDCK Permeability:  1.2584621799760498e-05
Pgp-inhibitor:  0.779
Pgp-substrate:  0.967
Human Intestinal Absorption (HIA):  0.206
20% Bioavailability (F20%):  0.892
30% Bioavailability (F30%):  0.049

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  98.15557098388672%
Volume Distribution (VD):  0.46
Pgp-substrate:  2.3475186824798584%

ADMET: Metabolism

CYP1A2-inhibitor:  0.248
CYP1A2-substrate:  0.856
CYP2C19-inhibitor:  0.207
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.772
CYP2C9-substrate:  0.676
CYP2D6-inhibitor:  0.159
CYP2D6-substrate:  0.172
CYP3A4-inhibitor:  0.132
CYP3A4-substrate:  0.103

ADMET: Excretion

Clearance (CL):  3.485
Half-life (T1/2):  0.464

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.948
Drug-inuced Liver Injury (DILI):  0.969
AMES Toxicity:  0.015
Rat Oral Acute Toxicity:  0.068
Maximum Recommended Daily Dose:  0.014
Skin Sensitization:  0.923
Carcinogencity:  0.068
Eye Corrosion:  0.003
Eye Irritation:  0.159
Respiratory Toxicity:  0.182

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470986

Natural Product ID:  NPC470986
Common Name*:   3-[[3-Acetyl-2,4,6-Trihydroxy-5-(3-Methylbut-2-Enyl)Phenyl]-Phenylmethyl]-4-Hydroxy-5-Propan-2-Yl-6-Propylpyran-2-One
IUPAC Name:   3-[[3-acetyl-2,4,6-trihydroxy-5-(3-methylbut-2-enyl)phenyl]-phenylmethyl]-4-hydroxy-5-propan-2-yl-6-propylpyran-2-one
Synonyms:  
Standard InCHIKey:  OIBBWFLGWHQBFZ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C31H36O7/c1-7-11-21-22(17(4)5)29(35)26(31(37)38-21)24(19-12-9-8-10-13-19)25-28(34)20(15-14-16(2)3)27(33)23(18(6)32)30(25)36/h8-10,12-14,17,24,33-36H,7,11,15H2,1-6H3
SMILES:  CCCc1oc(=O)c(c(c1C(C)C)O)C(c1c(O)c(CC=C(C)C)c(c(c1O)C(=O)C)O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2334818
PubChem CID:   71716407
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000369] Diphenylmethanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25148.1 Helichrysum italicum Under-species n.a. n.a. Flowered aerial parts Arzana, Sardinia 2010-Jul PMID[23265253]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[453923]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 6.0 ug.mL-1 PMID[453923]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 2.0 ug.mL-1 PMID[453923]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 4.0 ug.mL-1 PMID[453923]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 PMID[453923]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470986 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9549 High Similarity NPC470984
0.9474 High Similarity NPC470988
0.9429 High Similarity NPC181388
0.9398 High Similarity NPC185624
0.9357 High Similarity NPC178627
0.9357 High Similarity NPC469935
0.9357 High Similarity NPC196137
0.9357 High Similarity NPC1886
0.9338 High Similarity NPC470985
0.9338 High Similarity NPC470989
0.9291 High Similarity NPC470322
0.9291 High Similarity NPC154217
0.9286 High Similarity NPC94794
0.9286 High Similarity NPC470296
0.9286 High Similarity NPC112791
0.9286 High Similarity NPC196459
0.9286 High Similarity NPC188632
0.9286 High Similarity NPC87609
0.9248 High Similarity NPC470987
0.9248 High Similarity NPC21378
0.9231 High Similarity NPC469932
0.9214 High Similarity NPC36181
0.9161 High Similarity NPC469933
0.9161 High Similarity NPC161864
0.9161 High Similarity NPC208303
0.9155 High Similarity NPC25844
0.9091 High Similarity NPC249942
0.9091 High Similarity NPC297886
0.9091 High Similarity NPC140120
0.9085 High Similarity NPC469953
0.9078 High Similarity NPC297600
0.9065 High Similarity NPC112789
0.9065 High Similarity NPC19622
0.9048 High Similarity NPC469934
0.9034 High Similarity NPC474735
0.9021 High Similarity NPC57470
0.9014 High Similarity NPC11700
0.9007 High Similarity NPC282300
0.9 High Similarity NPC301217
0.9 High Similarity NPC19476
0.9 High Similarity NPC217186
0.9 High Similarity NPC303633
0.9 High Similarity NPC283429
0.9 High Similarity NPC275903
0.9 High Similarity NPC241975
0.9 High Similarity NPC53181
0.9 High Similarity NPC220062
0.9 High Similarity NPC55018
0.9 High Similarity NPC216978
0.9 High Similarity NPC96565
0.9 High Similarity NPC473209
0.8978 High Similarity NPC475088
0.8973 High Similarity NPC290671
0.8973 High Similarity NPC209142
0.8973 High Similarity NPC312549
0.8966 High Similarity NPC19238
0.8966 High Similarity NPC164205
0.8966 High Similarity NPC104236
0.8958 High Similarity NPC180477
0.8951 High Similarity NPC326500
0.8951 High Similarity NPC271288
0.8936 High Similarity NPC48624
0.8936 High Similarity NPC204985
0.8936 High Similarity NPC261227
0.8936 High Similarity NPC215311
0.8936 High Similarity NPC172250
0.8936 High Similarity NPC159275
0.8936 High Similarity NPC213659
0.8936 High Similarity NPC265178
0.8936 High Similarity NPC259166
0.8936 High Similarity NPC270883
0.8936 High Similarity NPC326109
0.8936 High Similarity NPC144118
0.8936 High Similarity NPC80962
0.8936 High Similarity NPC172986
0.8936 High Similarity NPC241100
0.8936 High Similarity NPC219917
0.8929 High Similarity NPC183639
0.8929 High Similarity NPC201395
0.8929 High Similarity NPC199458
0.8929 High Similarity NPC470083
0.8929 High Similarity NPC219584
0.8913 High Similarity NPC103842
0.8897 High Similarity NPC145467
0.8889 High Similarity NPC477955
0.8881 High Similarity NPC219915
0.8881 High Similarity NPC24821
0.8881 High Similarity NPC190637
0.8881 High Similarity NPC212932
0.8881 High Similarity NPC116513
0.8881 High Similarity NPC9117
0.8881 High Similarity NPC293053
0.8873 High Similarity NPC268204
0.8873 High Similarity NPC470555
0.8873 High Similarity NPC232021
0.8873 High Similarity NPC40118
0.8873 High Similarity NPC469404
0.8873 High Similarity NPC26051
0.8873 High Similarity NPC110969
0.8873 High Similarity NPC126534
0.8873 High Similarity NPC52789
0.8873 High Similarity NPC55832
0.8873 High Similarity NPC205006
0.8873 High Similarity NPC156590
0.8873 High Similarity NPC118840
0.8873 High Similarity NPC147688
0.8873 High Similarity NPC64908
0.8865 High Similarity NPC18260
0.8865 High Similarity NPC78913
0.8865 High Similarity NPC472343
0.8865 High Similarity NPC295384
0.8865 High Similarity NPC477956
0.8857 High Similarity NPC474624
0.8857 High Similarity NPC153979
0.8857 High Similarity NPC255801
0.8857 High Similarity NPC138047
0.8857 High Similarity NPC322301
0.8857 High Similarity NPC131782
0.8849 High Similarity NPC13575
0.8849 High Similarity NPC50455
0.8849 High Similarity NPC156092
0.8844 High Similarity NPC316960
0.8844 High Similarity NPC204561
0.8844 High Similarity NPC78835
0.8844 High Similarity NPC317715
0.8844 High Similarity NPC309512
0.8844 High Similarity NPC148945
0.8832 High Similarity NPC175738
0.8828 High Similarity NPC308200
0.8828 High Similarity NPC475348
0.8828 High Similarity NPC125801
0.8828 High Similarity NPC261271
0.8819 High Similarity NPC235217
0.8819 High Similarity NPC473014
0.8819 High Similarity NPC311741
0.8819 High Similarity NPC216538
0.8819 High Similarity NPC234629
0.8819 High Similarity NPC476055
0.8819 High Similarity NPC273538
0.8815 High Similarity NPC473017
0.8811 High Similarity NPC293852
0.8811 High Similarity NPC217083
0.8811 High Similarity NPC266725
0.8811 High Similarity NPC299080
0.8811 High Similarity NPC11561
0.8811 High Similarity NPC226636
0.8811 High Similarity NPC144499
0.8811 High Similarity NPC78803
0.8811 High Similarity NPC214236
0.8811 High Similarity NPC59739
0.8811 High Similarity NPC200694
0.8811 High Similarity NPC473042
0.8811 High Similarity NPC62840
0.8806 High Similarity NPC267846
0.8803 High Similarity NPC101366
0.8803 High Similarity NPC11056
0.8803 High Similarity NPC69769
0.8803 High Similarity NPC221173
0.8803 High Similarity NPC475680
0.8803 High Similarity NPC305355
0.8803 High Similarity NPC477272
0.8803 High Similarity NPC235239
0.8803 High Similarity NPC253822
0.8803 High Similarity NPC150522
0.8794 High Similarity NPC470669
0.8794 High Similarity NPC21350
0.8794 High Similarity NPC243528
0.8794 High Similarity NPC470668
0.8794 High Similarity NPC251681
0.8786 High Similarity NPC41461
0.8786 High Similarity NPC168105
0.8786 High Similarity NPC25287
0.8786 High Similarity NPC213603
0.8786 High Similarity NPC24394
0.8786 High Similarity NPC249606
0.8786 High Similarity NPC477242
0.8786 High Similarity NPC13408
0.8786 High Similarity NPC12165
0.8786 High Similarity NPC194579
0.8786 High Similarity NPC98115
0.8786 High Similarity NPC186838
0.8786 High Similarity NPC477244
0.8786 High Similarity NPC150399
0.8786 High Similarity NPC1486
0.8786 High Similarity NPC477243
0.8786 High Similarity NPC274109
0.8786 High Similarity NPC66349
0.8776 High Similarity NPC158866
0.8776 High Similarity NPC29777
0.8776 High Similarity NPC471115
0.8776 High Similarity NPC151973
0.8767 High Similarity NPC39195
0.8767 High Similarity NPC152233
0.8759 High Similarity NPC124729
0.8759 High Similarity NPC225173
0.8759 High Similarity NPC474161
0.8759 High Similarity NPC285630
0.8759 High Similarity NPC178343
0.8759 High Similarity NPC127059
0.8759 High Similarity NPC163846

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470986 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8819 High Similarity NPD4378 Clinical (unspecified phase)
0.869 High Similarity NPD7410 Clinical (unspecified phase)
0.86 High Similarity NPD7819 Suspended
0.8582 High Similarity NPD1510 Phase 2
0.8553 High Similarity NPD7075 Discontinued
0.8543 High Similarity NPD8443 Clinical (unspecified phase)
0.8531 High Similarity NPD970 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8467 Intermediate Similarity NPD7411 Suspended
0.8429 Intermediate Similarity NPD1240 Approved
0.8414 Intermediate Similarity NPD3750 Approved
0.84 Intermediate Similarity NPD4380 Phase 2
0.8366 Intermediate Similarity NPD7768 Phase 2
0.8333 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.831 Intermediate Similarity NPD1607 Approved
0.8291 Intermediate Similarity NPD7473 Discontinued
0.8289 Intermediate Similarity NPD6801 Discontinued
0.8276 Intermediate Similarity NPD1549 Phase 2
0.8264 Intermediate Similarity NPD2796 Approved
0.8235 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD2799 Discontinued
0.8194 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD2532 Approved
0.8188 Intermediate Similarity NPD2534 Approved
0.8188 Intermediate Similarity NPD2533 Approved
0.8182 Intermediate Similarity NPD6651 Approved
0.8138 Intermediate Similarity NPD2935 Discontinued
0.8121 Intermediate Similarity NPD6799 Approved
0.8121 Intermediate Similarity NPD1511 Approved
0.8101 Intermediate Similarity NPD6232 Discontinued
0.8095 Intermediate Similarity NPD2800 Approved
0.8095 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD1243 Approved
0.8077 Intermediate Similarity NPD3749 Approved
0.8069 Intermediate Similarity NPD3748 Approved
0.8039 Intermediate Similarity NPD6599 Discontinued
0.8028 Intermediate Similarity NPD2313 Discontinued
0.8028 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD5405 Approved
0.8014 Intermediate Similarity NPD5404 Approved
0.8014 Intermediate Similarity NPD5408 Approved
0.8014 Intermediate Similarity NPD5406 Approved
0.8013 Intermediate Similarity NPD1512 Approved
0.8 Intermediate Similarity NPD2801 Approved
0.8 Intermediate Similarity NPD7390 Discontinued
0.7963 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD3817 Phase 2
0.7935 Intermediate Similarity NPD1934 Approved
0.7929 Intermediate Similarity NPD1164 Approved
0.7919 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD943 Approved
0.7902 Intermediate Similarity NPD3268 Approved
0.7891 Intermediate Similarity NPD1551 Phase 2
0.7872 Intermediate Similarity NPD2798 Approved
0.7843 Intermediate Similarity NPD920 Approved
0.7815 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD6959 Discontinued
0.7801 Intermediate Similarity NPD2797 Approved
0.78 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3764 Approved
0.7771 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD5953 Discontinued
0.7744 Intermediate Similarity NPD7286 Phase 2
0.7742 Intermediate Similarity NPD3226 Approved
0.7727 Intermediate Similarity NPD5403 Approved
0.7718 Intermediate Similarity NPD2346 Discontinued
0.7712 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD1203 Approved
0.7673 Intermediate Similarity NPD3882 Suspended
0.7651 Intermediate Similarity NPD6100 Approved
0.7651 Intermediate Similarity NPD6099 Approved
0.7643 Intermediate Similarity NPD1201 Approved
0.764 Intermediate Similarity NPD5494 Approved
0.7636 Intermediate Similarity NPD7054 Approved
0.7628 Intermediate Similarity NPD7458 Discontinued
0.7609 Intermediate Similarity NPD9545 Approved
0.76 Intermediate Similarity NPD2344 Approved
0.7597 Intermediate Similarity NPD5401 Approved
0.7591 Intermediate Similarity NPD9493 Approved
0.759 Intermediate Similarity NPD7472 Approved
0.759 Intermediate Similarity NPD7074 Phase 3
0.7576 Intermediate Similarity NPD3818 Discontinued
0.7566 Intermediate Similarity NPD4628 Phase 3
0.7562 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD6166 Phase 2
0.7552 Intermediate Similarity NPD3266 Approved
0.7552 Intermediate Similarity NPD3267 Approved
0.7552 Intermediate Similarity NPD1470 Approved
0.7546 Intermediate Similarity NPD5710 Approved
0.7546 Intermediate Similarity NPD5711 Approved
0.7534 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD5844 Phase 1
0.7518 Intermediate Similarity NPD422 Phase 1
0.7517 Intermediate Similarity NPD6832 Phase 2
0.75 Intermediate Similarity NPD7251 Discontinued
0.75 Intermediate Similarity NPD5124 Phase 1
0.75 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5402 Approved
0.75 Intermediate Similarity NPD6559 Discontinued
0.75 Intermediate Similarity NPD230 Phase 1
0.7469 Intermediate Similarity NPD919 Approved
0.7467 Intermediate Similarity NPD4308 Phase 3
0.7467 Intermediate Similarity NPD7033 Discontinued
0.7465 Intermediate Similarity NPD1608 Approved
0.7465 Intermediate Similarity NPD9717 Approved
0.7456 Intermediate Similarity NPD7808 Phase 3
0.7456 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD7003 Approved
0.744 Intermediate Similarity NPD6797 Phase 2
0.7429 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD2309 Approved
0.7397 Intermediate Similarity NPD4908 Phase 1
0.7391 Intermediate Similarity NPD4288 Approved
0.7389 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD3225 Approved
0.7351 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7229 Phase 3
0.733 Intermediate Similarity NPD4363 Phase 3
0.733 Intermediate Similarity NPD4360 Phase 2
0.7329 Intermediate Similarity NPD1465 Phase 2
0.7314 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD4361 Phase 2
0.7288 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD8150 Discontinued
0.7273 Intermediate Similarity NPD1610 Phase 2
0.7261 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD9266 Approved
0.7259 Intermediate Similarity NPD74 Approved
0.7255 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD17 Approved
0.7218 Intermediate Similarity NPD5909 Discontinued
0.72 Intermediate Similarity NPD4287 Approved
0.72 Intermediate Similarity NPD4307 Phase 2
0.7197 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD9267 Approved
0.7185 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD9263 Approved
0.7185 Intermediate Similarity NPD9264 Approved
0.7181 Intermediate Similarity NPD1296 Phase 2
0.7161 Intermediate Similarity NPD2654 Approved
0.7152 Intermediate Similarity NPD6355 Discontinued
0.7152 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6585 Discontinued
0.7143 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD1283 Approved
0.7115 Intermediate Similarity NPD8166 Discontinued
0.7114 Intermediate Similarity NPD4625 Phase 3
0.7113 Intermediate Similarity NPD1548 Phase 1
0.711 Intermediate Similarity NPD8312 Approved
0.711 Intermediate Similarity NPD8313 Approved
0.7103 Intermediate Similarity NPD9269 Phase 2
0.7103 Intermediate Similarity NPD3972 Approved
0.7102 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD5890 Approved
0.7099 Intermediate Similarity NPD5889 Approved
0.7083 Intermediate Similarity NPD3926 Phase 2
0.7073 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD6190 Approved
0.7067 Intermediate Similarity NPD411 Approved
0.7066 Intermediate Similarity NPD7199 Phase 2
0.7066 Intermediate Similarity NPD1247 Approved
0.7063 Intermediate Similarity NPD9268 Approved
0.7059 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD37 Approved
0.7048 Intermediate Similarity NPD6234 Discontinued
0.7039 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD447 Suspended
0.7039 Intermediate Similarity NPD1933 Approved
0.7034 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6002 Phase 3
0.7032 Intermediate Similarity NPD6005 Phase 3
0.7032 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6004 Phase 3
0.703 Intermediate Similarity NPD4966 Approved
0.703 Intermediate Similarity NPD4967 Phase 2
0.703 Intermediate Similarity NPD4965 Approved
0.7018 Intermediate Similarity NPD6020 Phase 2
0.7015 Intermediate Similarity NPD1929 Approved
0.7015 Intermediate Similarity NPD1931 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD1930 Approved
0.7 Intermediate Similarity NPD5049 Phase 3
0.6989 Remote Similarity NPD8434 Phase 2
0.6982 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6974 Remote Similarity NPD4060 Phase 1
0.6972 Remote Similarity NPD405 Clinical (unspecified phase)
0.6968 Remote Similarity NPD4477 Approved
0.6968 Remote Similarity NPD4476 Approved
0.6954 Remote Similarity NPD6798 Discontinued
0.695 Remote Similarity NPD9281 Approved
0.695 Remote Similarity NPD5951 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data